Fluorescent pegylated nanoparticles demonstrate fluid-phase pinocytosis by macrophages in mouse atherosclerotic lesions.
暂无分享,去创建一个
H. Kruth | M. Amar | Chiara Buono | Joshua J Anzinger | Marcelo Amar | Howard S Kruth | J. Anzinger | C. Buono
[1] K. Moore,et al. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. , 2005, The Journal of clinical investigation.
[2] A. Gotto,et al. Apo B concentration in the normal human aorta. , 1978, Biochemical and biophysical research communications.
[3] D. Steinberg. Oxidative Modification of LDL and Atherogenesis , 1998 .
[4] C. Norbury. Drinking a lot is good for dendritic cells , 2006, Immunology.
[5] E. B. Smith. Transport, interactions and retention of plasma proteins in the intima: the barrier function of the internal elastic lamina. , 1990, European heart journal.
[6] D. Bilheimer,et al. Role of receptor-independent low density lipoprotein transport in the maintenance of tissue cholesterol balance in the normal and WHHL rabbit. , 1987, Journal of lipid research.
[7] J. Richardson,et al. Receptor-mediated and bulk-phase endocytosis cause macrophage and cholesterol accumulation in Niemann-Pick C disease Published, JLR Papers in Press, May 2, 2007. , 2007, Journal of Lipid Research.
[8] M. Febbraio,et al. Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II. , 2008, Cardiovascular research.
[9] G. Hansson. Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.
[10] E. Rubin,et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells , 1992, Cell.
[11] P. Libby,et al. Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. , 1992, The American journal of pathology.
[12] Ira Tabas,et al. Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. , 2002, The Journal of clinical investigation.
[13] R. S. St. Clair,et al. A comparative microscopic and biochemical study of the uptake of fluorescent and 125I-labeled lipoproteins by skin fibroblasts, smooth muscle cells, and peritoneal macrophages in culture. , 1985, The American journal of pathology.
[14] W. Kannel,et al. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. , 1979, Annals of internal medicine.
[15] C. Ashall,et al. Low-density lipoprotein concentration in interstitial fluid from human atherosclerotic lesions. Relation to theories of endothelial damage and lipoprotein binding. , 1983, Biochimica et biophysica acta.
[16] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[17] Stephen W. Waldo,et al. Heterogeneity of human macrophages in culture and in atherosclerotic plaques. , 2008, The American journal of pathology.
[18] S. Gordon,et al. Expression of a mannosyl-fucosyl receptor for endocytosis on cultured primary macrophages and their hybrids , 1982, The Journal of cell biology.
[19] K. Akagawa,et al. Enhancement of macrophage colony-stimulating factor-induced growth and differentiation of human monocytes by interleukin-10. , 1997, Blood.
[20] M. Brown,et al. The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages. , 1980, Journal of supramolecular structure.
[21] H. Kruth,et al. Macrophage Foam Cell Formation with Native Low Density Lipoprotein* , 2002, The Journal of Biological Chemistry.
[22] Stephen W. Waldo,et al. Constitutive Receptor-independent Low Density Lipoprotein Uptake and Cholesterol Accumulation by Macrophages Differentiated from Human Monocytes with Macrophage-Colony-stimulating Factor (M-CSF)* , 2006, Journal of Biological Chemistry.
[23] S. Yap,et al. Changes in fluid-phase endocytosis in the rat with age and their relation to total albumin elimination , 1986, Mechanisms of Ageing and Development.
[24] Z. F. Stephan,et al. Rapid fluorometric assay of LDL receptor activity by DiI-labeled LDL. , 1993, Journal of lipid research.
[25] H. Kruth. Histochemical detection of esterified cholesterol within human atherosclerotic lesions using the fluorescent probe filipin. , 1984, Atherosclerosis.
[26] Wan-Wan Lin,et al. Protein kinase C β and δ isoenzymes mediate cholesterol accumulation in PMA-activated macrophages , 2006 .
[27] D. Steinberg,et al. Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. , 1997, Circulation.
[28] M. Brown,et al. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[29] Ming-Hsien Tsai,et al. Persistent Tissue Kinetics and Redistribution of Nanoparticles, Quantum Dot 705, in Mice: ICP-MS Quantitative Assessment , 2007, Environmental health perspectives.
[30] R. Collins,et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths , 2007, The Lancet.
[31] V. Ord,et al. Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans. , 1992, The American journal of pathology.
[32] D. Malide,et al. Macropinocytosis Is the Endocytic Pathway That Mediates Macrophage Foam Cell Formation with Native Low Density Lipoprotein* , 2005, Journal of Biological Chemistry.
[33] C. Packard,et al. Receptor-independent catabolism of low density lipoprotein. Involvement of the reticuloendothelial system. , 1982, The Journal of biological chemistry.
[34] Marcel Mettlen,et al. Origin, originality, functions, subversions and molecular signalling of macropinocytosis. , 2002, International journal of medical microbiology : IJMM.
[35] K. Moore,et al. Scavenger Receptors Class A-I/II and CD36 Are the Principal Receptors Responsible for the Uptake of Modified Low Density Lipoprotein Leading to Lipid Loading in Macrophages* , 2002, The Journal of Biological Chemistry.
[36] R. Mahley,et al. Foam Cells in Explants of Atherosclerotic Rabbit Aortas Have Receptors for β‐Very Low Density Low Density Lipoproteins and Modified Low Density Lipoproteins , 1983, Arteriosclerosis.
[37] Y. Bobryshev,et al. Monocyte recruitment and foam cell formation in atherosclerosis. , 2006, Micron.
[38] C. Packard,et al. The reticuloendothelial system and low density lipoprotein metabolism in the rabbit. , 1982, Biochimica et biophysica acta.
[39] Stephen W. Waldo,et al. Liver X receptors inhibit human monocyte-derived macrophage foam cell formation by inhibiting fluid-phase pinocytosis of LDL Published, JLR Papers in Press, August 10, 2007. , 2007, Journal of Lipid Research.